Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia. - Wikidata - wikimedia - TriplyDB

Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia.

Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia.

http://www.wikidata.org/entity/Q33336772

about

Heparin-induced thrombocytopenia in the ICU: an overview Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of deep vein thrombosis Venous thromboembolic disease Heparin induced thrombocytopenia: diagnosis and management update Heparin-induced thrombocytopenia: an update Transitioning from argatroban to warfarin therapy in patients with heparin-induced thrombocytopenia Lepirudin in patients with heparin-induced thrombocytopenia - results of the third prospective study (HAT-3) and a combined analysis of HAT-1, HAT-2, and HAT-3 A comparison of lepirudin and argatroban outcomes Treatment of heparin-induced thrombocytopenia.Use of lepirudin in patients with heparin-induced thrombocytopenia and renal failure requiring hemodialysis.Anticoagulation for acute coronary syndromes and percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.Drug-induced and drug-dependent immune thrombocytopenias.Heparin-induced thrombocytopenia: pathophysiology and management.Therapeutic considerations in the management of patients with heparin-induced thrombocytopenia.RNA aptamers as reversible antagonists of coagulation factor IXa.Argatroban anticoagulation during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.Preventing complications in heparin-induced thrombocytopenia. Alternative anticoagulants are improving patient outcomes.Monitoring of argatroban in ARG310 study: potential recommendations for its use in interventional cardiology.Tackling the devastating effects of heparin-induced thrombocytopenia.Alternative methods of anticoagulation for dialysis-dependent patients with heparin-induced thrombocytopenia.On the prophylactic and therapeutic use of danaparoid sodium (Orgaran) in patients with heparin-induced thrombocytopenia.Diagnosis and treatment of heparin-induced thrombocytopenia.Heparin-induced thrombocytopenia: pathogenesis and management.Argatroban dosing in patients with heparin-induced thrombocytopenia.Heparin-induced thrombocytopenia--recognition and treatment.Danaparoid for heparin-induced thrombocytopenia: an analysis of treatment failures.Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD.Laboratory diagnosis of heparin-induced thrombocytopenia and monitoring of alternative anticoagulants Argatroban use during pediatric interventional cardiac catheterization.Drugs for the prevention and treatment of thrombosis in patients with heparin-induced thrombocytopenia.Unfractionated heparin: focus on a high-alert drug.Towards a diagnosis of heparin-induced thrombocytopenia after cardiopulmonary bypass.Argatroban and renal replacement therapy in patients with heparin-induced thrombocytopenia.New developments in diagnosis and treatment of heparin-induced thrombocytopenia.Coronary artery stent thrombosis associated with heparin-induced thrombocytopenia: case report and review of the literature.Acute left main occlusion during percutaneous coronary intervention associated with heparin induced thrombocytopenia with thrombosis syndrome.Treatment of patients with a history of heparin-induced thrombocytopenia and anti-lepirudin antibodies with argatroban.Transitioning from argatroban to warfarin in heparin-induced thrombocytopenia: an analysis of outcomes in patients with elevated international normalized ratio (INR).Fondaparinux: a potential new therapy for HIT.Argatroban anticoagulation in patients with heparin-induced thrombocytopenia requiring renal replacement therapy.

P2860

Q21194907-8F61378B-E63A-49D6-94B4-235913526358 Q24200867-43436954-9B96-42EE-B77F-61B6E158376C Q24631121-106F47DB-5E3E-404F-B98B-79B8C0B1043D Q24647207-B28A7D41-53DE-4463-8180-57AE6744F8F2 Q24815767-13595C0C-D7F1-402E-B924-0C94ECF5FB4B Q28261518-27234FA0-2FAE-4610-99F4-4EADAFDA3B49 Q28278419-86E54010-E5AF-4B9F-899C-6E2BDD4DC898 Q28278668-D266D449-E9E0-462B-A2CD-889545FF79D5 Q31042575-DB8760A6-73C0-4728-AB6D-8EAA37EFF5D3 Q33338402-CA78224F-D1E5-4D4C-B59D-A55ECDE7CD6C Q33338529-3FF8B026-4D33-4767-B071-9A7CB991D5E8 Q33339739-3E922084-7B22-4977-B405-891DA65252ED Q33342924-D5F340B7-6A3E-4835-ACDA-DB3BCDAF6827 Q33343054-6D43B0D5-3637-4746-9427-6D14705429EA Q33344114-98AA3E0E-D37F-4C7C-A8E9-3F8FBDE2375C Q33344475-99422147-ABEC-4288-9ED9-08F2D4B5364F Q33344512-75B10003-EBE9-4171-97D7-6FBC4D79DAFD Q33344535-8282BF1F-AA43-44B0-9343-89D62219D299 Q33345517-BAD8C5DC-20F4-4238-B25C-FFF3E0B09150 Q33346149-F6AC495A-8648-41BF-9DB0-080C07069DFD Q33347011-EF7C6380-2235-44AB-A5E6-1F2D3DBE8336 Q33347578-A1D54D38-0857-4AFA-9CDA-3BFA6E8BF6EC Q33348049-5645749E-45F4-4BAF-BC80-7F2228DA64DC Q33348817-16F0D8E6-702C-40DF-A11D-B361EE696226 Q33349198-64F5D677-F232-4EE5-875D-5E7555B46C00 Q33349237-CEF010AA-BFA3-4FC0-9F65-F1E48A168294 Q33349541-9185578C-6825-4324-99ED-3099C785EC51 Q33349870-F3921E23-FB72-4886-990A-150B50A0F2CF Q33358349-BF5F669E-8CA1-4A1F-AB73-50B26A1F03F1 Q33358613-F91DBB79-F0A2-48A0-9E80-B8ED651FAA53 Q33362322-A49FADCA-941B-4E47-B0A8-E2B4AB339603 Q33363740-751711B3-3D44-45F8-B7A3-68A594969BF1 Q33364404-E4507978-574B-4D19-9A63-AE7B5F8065FA Q33364828-63E25A3F-D58A-4F03-B4B9-D64846489CFA Q33366197-9F1B8315-FC7F-41B7-B6AD-8D3797C8E734 Q33366200-90B21367-3F11-493A-BD90-EE6440E20AAB Q33366919-C7187687-283B-4141-8E1C-1B7FA1852354 Q33367685-08AAEAC5-903E-4D1A-81D3-7C9439AC6EFC Q33367708-75EA2E07-40A4-4DEC-B4AC-139D9BD617AF Q33368191-A6C1CEEE-6944-4657-8C16-990414776EBA

P2860

Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia.

http://www.wikidata.org/entity/Q33336772

description

2001 nî lūn-bûn

@nan

2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia.

@ast

Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia.

@en

Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia.

@nl

type

label

Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia.

@ast

Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia.

@en

Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia.

@nl

prefLabel

Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia.

@ast

Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia.

@en

Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia.

@nl

P1433

Q33336772-DBB44742-706B-433B-9F1A-BBC934A6D743

P1476

Q33336772-6AB7231A-8909-4990-A2F5-86710247CEB7

P2093

Q33336772-1131F994-E94B-4ED2-9290-94D0865E7740

Q33336772-2A6F297E-D2E2-4E50-B283-F6C732325B4A

Q33336772-411A223B-F982-499F-9E92-C71A793149B9

Q33336772-489E5044-940E-4744-8DFE-EEFF3B9B6BB4

Q33336772-49504F6F-7EB6-4CC2-8604-1943B14CD8AC

Q33336772-861EA316-D211-46F0-A07D-6FCFCD533C34

Q33336772-A6E22AC9-DF0E-4872-B083-390183CC8500

Q33336772-A8A9A545-5EA0-4688-8E95-0CF776D48CD4

Q33336772-B6E99019-3C6F-4D4E-A5AA-1C368D1E0B62

Q33336772-BEAFDBB3-6A5A-4093-9032-C4ED498365FE

P304

Q33336772-E19E33AB-44C4-47D5-8922-BF54D621A0E7

P31

Q33336772-CE850D66-C784-40B4-A9C6-928AFE848186

P356

Q33336772-405E3636-AF07-4810-9D8C-EECC505716D1

P407

Q33336772-A903F940-D3B9-47FD-A376-903E844E9752

P433

Q33336772-5CC7C612-A99D-47FA-8E39-59967D360611

P478

Q33336772-3DF11674-6592-46DC-A8AE-C74972FC3128

P50

Q33336772-9AF7D3E1-D205-4878-BCD4-54E2C0BEC6ED

P577

Q33336772-793304B5-5090-494D-802F-830661674D08

P698

Q33336772-AC1B3D6F-7F9D-41E4-B5A4-418760691377

P921

Q33336772-CCC557B7-3E43-4D8A-AD8D-C2CFDA0806C2

Q33336772-F713C19E-02B5-44AC-BD5E-D478CFF488F7

P356

01.CIR.103.14.1838

P1433

P1476

Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia

@en

P2093

ARG-911 Study Investigators

http://www.w3.org/2001/XMLSchema#string

B E Lewis

http://www.w3.org/2001/XMLSchema#string

D E Wallis

http://www.w3.org/2001/XMLSchema#string

I K Jang

http://www.w3.org/2001/XMLSchema#string

J Bartholomew

http://www.w3.org/2001/XMLSchema#string

J Fareed

http://www.w3.org/2001/XMLSchema#string

J G Kelton

http://www.w3.org/2001/XMLSchema#string

J M Walenga

http://www.w3.org/2001/XMLSchema#string

J Moran

http://www.w3.org/2001/XMLSchema#string

M J Hursting

http://www.w3.org/2001/XMLSchema#string

P304

1838-1843

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/01.CIR.103.14.1838

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P50

Scott D Berkowitz

P577

2001-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11294800

http://www.w3.org/2001/XMLSchema#string

P921

thrombocytopenia

anticoagulation